Steven Verdooner

1.6k total citations · 1 hit paper
14 papers, 656 citations indexed

About

Steven Verdooner is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Steven Verdooner has authored 14 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Ophthalmology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Physiology. Recurrent topics in Steven Verdooner's work include Retinal Diseases and Treatments (6 papers), Alzheimer's disease research and treatments (5 papers) and Glaucoma and retinal disorders (5 papers). Steven Verdooner is often cited by papers focused on Retinal Diseases and Treatments (6 papers), Alzheimer's disease research and treatments (5 papers) and Glaucoma and retinal disorders (5 papers). Steven Verdooner collaborates with scholars based in United States, Australia and United Kingdom. Steven Verdooner's co-authors include Maya Koronyo‐Hamaoui, Keith L. Black, Yosef Koronyo, Sally A. Frautschy, Ephraim Friedman, David R. Guyer, Jordi Monés, Carmen A. Puliafito, David Biggs and Dieu‐Trang Fuchs and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Journal of Alzheimer s Disease.

In The Last Decade

Steven Verdooner

13 papers receiving 643 citations

Hit Papers

Retinal amyloid pathology and proof-of-concept imaging tr... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease
    2017 350 citations Yosef Koronyo, David Biggs et al. JCI Insight profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Verdooner United States 9 366 301 190 153 84 14 656
Alessio Martucci Italy 17 614 1.7× 365 1.2× 68 0.4× 237 1.5× 162 1.9× 41 862
Hannah Youngblood United States 10 181 0.5× 121 0.4× 44 0.2× 180 1.2× 54 0.6× 14 459
Verena Prokosch Germany 18 539 1.5× 209 0.7× 61 0.3× 307 2.0× 85 1.0× 79 851
Fernando Galassi Italy 14 680 1.9× 383 1.3× 103 0.5× 219 1.4× 102 1.2× 19 903
İclal Yücel Türkiye 17 506 1.4× 290 1.0× 49 0.3× 151 1.0× 66 0.8× 38 787
Ingrida Janulevičienė Lithuania 17 764 2.1× 460 1.5× 28 0.1× 107 0.7× 58 0.7× 71 920
E N Su Australia 12 401 1.1× 261 0.9× 90 0.5× 271 1.8× 31 0.4× 16 602
Rachael S Allen United States 12 295 0.8× 132 0.4× 29 0.2× 296 1.9× 76 0.9× 33 567
Josef Flammer Germany 7 461 1.3× 200 0.7× 51 0.3× 105 0.7× 85 1.0× 8 510

Countries citing papers authored by Steven Verdooner

Since Specialization
Citations

This map shows the geographic impact of Steven Verdooner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Verdooner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Verdooner more than expected).

Fields of papers citing papers by Steven Verdooner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Verdooner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Verdooner. The network helps show where Steven Verdooner may publish in the future.

Co-authorship network of co-authors of Steven Verdooner

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Verdooner. A scholar is included among the top collaborators of Steven Verdooner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Verdooner. Steven Verdooner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Dumitrascu, Oana M., Jonah Doustar, Dieu‐Trang Fuchs, et al.. (2024). Retinal peri-arteriolar versus peri-venular amyloidosis, hippocampal atrophy, and cognitive impairment: exploratory trial. Acta Neuropathologica Communications. 12(1). 109–109. 8 indexed citations
2.
Verdooner, Steven, et al.. (2024). Remote APOE counseling and genotyping via telehealth: Early findings from a new care delivery model in the United States. Alzheimer s & Dementia. 20(S8). 1 indexed citations
3.
Rauramaa, Tuomas, Sanna‐Kaisa Herukka, Anne M. Koivisto, et al.. (2024). Exploring the Association Between Visual Field Testing and CERAD Neuropsychological Battery in Idiopathic Normal Pressure Hydrocephalus Patients. Journal of Alzheimer s Disease. 100(1). 247–260. 1 indexed citations
4.
Oakley, Jonathan D., Steven Verdooner, Daniel B. Russakoff, et al.. (2022). QUANTITATIVE ASSESSMENT OF AUTOMATED OPTICAL COHERENCE TOMOGRAPHY IMAGE ANALYSIS USING A HOME-BASED DEVICE FOR SELF-MONITORING NEOVASCULAR AGE-RELATED MACULAR DEGENERATION. Retina. 43(3). 433–443. 8 indexed citations
5.
Dumitrascu, Oana M., Ryan Rosenberry, Dale Sherman, et al.. (2021). Retinal Venular Tortuosity Jointly with Retinal Amyloid Burden Correlates with Verbal Memory Loss: A Pilot Study. Cells. 10(11). 2926–2926. 15 indexed citations
6.
Dumitrascu, Oana M., Patrick D. Lyden, Tania Torbati, et al.. (2020). Sectoral segmentation of retinal amyloid imaging in subjects with cognitive decline. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12109–e12109. 38 indexed citations
7.
Hampel, Harald, Andrea Vergallo, Mohammad Afshar, et al.. (2019). Blood-based systems biology biomarkers for next-generation clinical trials in Alzheimer’s disease. Dialogues in Clinical Neuroscience. 21(2). 177–191. 17 indexed citations
8.
Koronyo, Yosef, David Biggs, Ernesto Barrón, et al.. (2017). Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer’s disease. JCI Insight. 2(16). 350 indexed citations breakdown →
9.
Frost, Shaun, Yogesan Kanagasingam, Lance Macaulay, et al.. (2014). O3‐13‐01: RETINAL AMYLOID FLUORESCENCE IMAGING PREDICTS CEREBRAL AMYLOID BURDEN AND ALZHEIMER'S DISEASE. Alzheimer s & Dementia. 10(4S_Part_4). 21 indexed citations
10.
Koronyo, Yosef, David Biggs, Ernesto Barrón, et al.. (2014). P3‐107: RETINAL IMAGING OF AB DEPOSITS IN AD PATIENTS: FROM HISTOLOGICAL EXAMINATION TO CLINICAL TRIALS. Alzheimer s & Dementia. 10(4S_Part_18). 1 indexed citations
11.
Blumenkranz, Mark S., Kathryn W. Woodburn, Qing Fan, et al.. (2000). Lutetium texaphyrin (Lu-Tex): a potential new agent for ocular fundus angiography and photodynamic therapy. American Journal of Ophthalmology. 129(3). 353–362. 45 indexed citations
12.
Guyer, David R., C. A. Puliafito, Jordi Monés, et al.. (1995). Digital Indocyanine Green Angiography in Chorioretinal Disorders. Retina. 15(1). 75–75. 12 indexed citations
13.
Hetherington, John, et al.. (1994). Repeatability of the Glaucoma-Scope Measurements of Optic Nerve Head Topography. Journal of Glaucoma. 3(1). 17???27–17???27. 7 indexed citations
14.
Guyer, David R., et al.. (1992). Digital Indocyanine-green Angilography in Chorioretinal Disorders. Ophthalmology. 99(2). 287–291. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessio Martucci Breakdown of academic impact, for papers by Hannah Youngblood Breakdown of academic impact, for papers by Verena Prokosch Breakdown of academic impact, for papers by Fernando Galassi Breakdown of academic impact, for papers by İclal Yücel Breakdown of academic impact, for papers by Ingrida Janulevičienė Breakdown of academic impact, for papers by E N Su Breakdown of academic impact, for papers by Rachael S Allen Breakdown of academic impact, for papers by Josef Flammer
Rankless by CCL
2026